Numinus Prepares for Psychedelics' Red-Letter Day
Numinus prepares for upcoming MDMA approval. Numinus has provided an update on its preparations for the highly anticipated upcoming FDA approval of MAPS' MDMA-Assisted Therapy (MDMA-AT) for PTSD. As we noted in our Shroom Shmooz edition from May 12, after generating stellar results through the clinical trial process, MAPS is expected to submit its new drug application (NDA) for marketing approval of the treatment in the next quarter with the expectation of getting FDA approval to market MDMA-AT by April or May 2024. This will make MDMA the first banned psychedelic to be federally legalized...Rojo Resources is an exploration stage company. Co. is engaged in the mineral exploration activities in Canada, the United States and Mongolia.
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.